The improvements in bacterial clearance and inflammation were associated with a reduction in lung injury at 48 h post-infection, as assessed by histological methods, that was more pronounced in mice treated with HIF-1α stabilized MSCs (Figures 2J,K). This evidence concerns the gene HIF1A and infection.